Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 11/20 | 0.77 |
| ▸ | MEN1 | O00255 | 7/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | ESR1 | P03372 | 6/20 | 0.67 |
| ▸ | CASP3 | P42574 | 2/20 | 0.65 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.65 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.65 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.60 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | PKM | P14618 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.53 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.52 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Betanaphthol SCHEMBL16236859 | 0.97 | KMT2A (0.84) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL14885201 | 0.92 | KMT2A (0.71) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL11297653 | 0.89 | KMT2A (0.61) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL30523105 | 0.87 | KMT2A (1.00) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL8080214 | 0.87 | KMT2A (0.66) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL1639878 | 0.87 | KMT2A (1.00) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL18058690 | 0.87 | KMT2A (0.93) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL18608268 | 0.87 | KMT2A (0.68) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL8461218 | 0.86 | KMT2A (0.58) | KMT2AMEN1MAPTTDP1ESR1 | |
| SCHEMBL8851038 | 0.86 | KMT2A (0.77) | KMT2AMEN1MAPTTDP1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935395-B2 | Liquid crystal molecule, liquid crystal display device and liquid crystal optical spatial modulation device | SONY CORPORATION (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20100085530-A1 | LIQUID CRYSTAL MOLECULE, LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL OPTICAL SPATIAL MODULATION DEVICE | SONY CORPORATION (JP) | 2010-04-08 | — | — | US | disclosed |
| US-20080027023-A1 | Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives | GLUCOGENE MEDICAL HFM AB (SE) | 2008-01-31 | — | — | US | disclosed |
| EP-1765363-A2 | NEW COMPOSITIONS | GLUCOGENE MEDICAL HFM AB (SE) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006006933-A2 | ANTIPROLIFERATIVE COMPOSITIONS COMPRISING ARYL SUBSTITUTED XYLOPYRANOSIDE DERIVATIVES | GLUCOGENE MEDICAL HFM AB (SE) | 2006-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100085530-A1 | LIQUID CRYSTAL MOLECULE, LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL OPTICAL SPATIAL MODULATION DEVICE | CXCR1, CXCR5, CXCR2 | KMT2A 3545/4885MEN1 1747/4885MAPT 3836/4885 |
| US-20080027023-A1 | Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives | UGGT1, B3GAT3, MKI67 | KMT2A 2348/4885MEN1 4507/4885MAPT 4677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.